GlaxoSmithKline S.A.E reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was EGP 460.66 million compared to EGP 370.18 million a year ago. Net income was EGP 13.81 million compared to EGP 869.16 million a year ago.

Basic earnings per share was EGP 0.17 compared to EGP 10.41 a year ago.